Bevacizumab boosts visual acuity in diabetes patients

04/9/2012 | MedPage Today (free registration)

Patients with diabetic macular edema who received intravitreal bevacizumab shots retained better visual acuity than those who underwent laser photocoagulation, according to a study in the Archives of Ophthalmology. The patients were evaluated one year and two years after the treatments.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC